Simvastatin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 5 mg, 10 mg, 20 mg, 40 mg, 80 mg
Reference Brands: Zocor(US & EU)
Category:
Heart Disorder
Simvastatin inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver. It effectively lowers LDL cholesterol, raises HDL, and reduces cardiovascular risk. Benefits include preventing heart attacks, strokes, and atherosclerosis, supporting long-term heart health, improving lipid profiles, and reducing morbidity and mortality from cardiovascular diseases.
Simvastatin tablets is available in Tablet
and strengths such as 5 mg, 10 mg, 20 mg, 40 mg, 80 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Simvastatin tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Simvastatin tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Simvastatin tablets, marketed as Zocor, are approved in the US by the FDA and in the EU via EMA for managing hyperlipidemia and reducing cardiovascular risk. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and manufacturing data, while the EMA ensures compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring regional adherence supports timely approval, safe use, and global availability of simvastatin tablets, helping patients worldwide prevent cardiovascular events and improve long-term heart health.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing